Clinical Trial Update: Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating atezolizumab in combination with neoadjuvant chemotherapy for newly diagnosed advanced-stage ovarian cancer has completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• neoadjuvant chemotherapy

Snippet

Sponsor: Duke University | Conditions: Ovarian Cancer, Ovarian Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-08-10